The Liver Meeting 2021-Part I - Increased-risk Organs

Video Transcription

Video Summary

Organ transplant surgery workshops often explore various surgical options for expanding the organ supply for liver transplantation. In a recent session, topics include the use of increased risk organs such as steatotic livers and donors with a history of cancer. Domino liver transplantation, the use of older donors, DCD donors, and recovery from infected donor organs were also discussed. The impact of fatty liver disease on liver transplants was highlighted, emphasizing the increasing prevalence of fatty liver in the general population and its implications for organ acceptance in transplant surgeries.<br /><br />When considering organ recovery from infected donors, the key factors to assess include the severity and extent of the infection, the risk of donor-derived transmission, the potential impact on recipient outcomes, and the strategies for mitigating these risks. Evaluating the donor's medical history, infectious disease testing, and the timing of infection onset are crucial in making informed decisions on organ utilization. In cases like COVID-19 positive donors, a thorough risk assessment and understanding of the disease progression are essential in determining the suitability of organs for transplant. Preemptive therapy and appropriate recipient preparation play a key role in ensuring safe transplantation and minimizing the risk of infection transmission. Additionally, vaccination of transplant candidates and careful monitoring post-transplant are important strategies in maintaining successful transplant outcomes while minimizing the risk of infection transmission. Overall, with careful assessment, proper precautions, and effective management strategies, the utilization of organs from infected donors can be conducted safely and effectively to support organ transplantation efforts.

Keywords

Organ transplant surgery workshops

Liver transplantation

Expanded organ supply

Steatotic livers

Domino liver transplantation

DCD donors

Fatty liver disease

Infected donor organs

Donor-derived transmission

COVID-19 positive donors

Preemptive therapy

Infection transmission risk